Stock CSBR CHAMPIONS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Delayed Nasdaq
Other stock markets
 10:55:12 2024-06-04 am EDT 		5-day change 1st Jan Change
4.77 USD 0.00% Intraday chart for Champions Oncology, Inc. +4.38% -15.12%
Mar. 15 Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. CI
Mar. 13 Craig-Hallum Downgrades Champions Oncology to Hold From Buy MT

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Craig-Hallum Downgrades Champions Oncology to Hold From Buy
MT
Craig Hallum Trims Champions Oncology Price target to $9 From $10, Maintains Buy Rating
MT
Roth MKM Adjusts Price Target on Champions Oncology to $7.50 From $9, Maintains Buy Rating
MT
Benchmark Company Downgrades Champions Oncology to Hold From Speculative Buy
MT
Craig Hallum Adjusts Champions Oncology Price Target to $10 From $12, Maintains Buy Rating
MT
CHAMPIONS ONCOLOGY : Roth Capital Adjusts Price Target on Champions Oncology to $16 From $13.50, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CSBR Stock
  4. News Champions Oncology, Inc.
  5. Analyst Reco.